Abstract
Arab Society for Pediatric Endocrinology and Diabetes (ASPED) Masterclass in Pediatric Bone Disease 2nd November 2018, Dubai, United Arab Emirates
Highlights
The Arab society of Paediatric Endocrinology and diabetes held a masterclass for paediatric bone diseases in Dubai, United Arab Emirates (UAE) in collaboration of Kyowa Kirin
Its aim is to ensure a high standard of care and development in the field of paediatric endocrinology and diabetes in the Arab region extending from the Gulf through the Northern African countries
On follow-up, while progression of fibrous dysplasia (FD) has been positively impacted with zoledronic acid in terms of lack of new lesions and improvement of bone mineral density (BMD), the main challenge identified with this patient was persistent elevation of FGF23 and phosphaturia, which may be the result of non-adherence to rickets treatment
Summary
Founded in 1949 in Japan, and is expanding globally. Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company contributing to human health and well-being worldwide. The company contribution is through innovative drug discovery and global commercialisation driven by state-of-the-art antibody technologies mainly in the core therapeutic areas of oncology, nephrology and immunology
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: American Journal of Biomedical Science & Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.